Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegavivint in Metastatic Colorectal Carcinoma
NCT07463599Phase 2Recruiting
- Sponsor
- HonorHealth Research Institute
- Start
- Feb 2026
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegavivint in colorectal cancer (CRC), sponsored by HonorHealth Research Institute. Started Feb 2026; status: recruiting.
02
Drugs
tegavivint
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07463599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07463599.